Exploiting the immune system: Toward new vaccines against intracellular bacteria

Advances in Immunology

Volumn 75, Issue , 2000, Pages 1-88

  Hess, Jürgen ^a   Schaible, Ulrich ^a   Raupach, Bärbel ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA VACCINE; DRUG CARRIER; IMMUNOLOGICAL ADJUVANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEOME; SALMONELLOSIS VACCINE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CHLAMYDIA; DRUG EFFICACY; GENE TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LISTERIA; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; VACCINATION;

EID: 0033946269     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2776(00)75001-2     Document Type: Review

References (422)

1. Abdelhak, S., Louzir, H., Timm, J., Blel, L., Benlasfar, Z., Lagranderie, M., Gheorghiu, M., Dellagi, K., and Gicquel, B. (1995). Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice. Microbiology 141, 1585-1592.
2. Aggarwal, A., Kumar, S., Jaffe, R., Hone, D., Gross, M., and Sadoff, J. (1990). Oral Salmonella: Malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med. 172, 1083-1090.
3. Akbari, O., Panjwani, N., Garcia, S., Tascon, R., Lowrie, D., and Stockinger, B. (1999). DNA vaccination: Transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189, 169-178.
4. Alarcon, J. B., Waine, G. W., and McManus, D. P. (1999). DNA vaccines: Technology and application as anti-parasite and anti-microbial agents. Adv. Parasitol. 42, 343-410.
5. Albert, M. L., Sauter, B., and Bhardwaj, N. (1998). Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature 392, 86-89.
6. Aldovini, A., and Young, R. A. (1999). Recombinant BCG vaccines. In "Intracellular Bacterial Vaccine Vectors" (Y. Paterson, ed.), pp. 151-170, John Wiley & Sons, New York, Chicester, Weinheim, Brisbane, Singapore, Toronto.
7. Aldovini, A., and Young, R. A. (1991). Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351, 479-482
8. Aliprantis A. O., Yang, R.-B, Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R., Godowski, P., and Zychlinski, A. (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739.
9. Alpuche-Aranda, C. M., Berthiaume, E. P., Mock, B., Swanson, J. A., and Miller, S. I. (1995). Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility. Inf. Immun. 63, 4456-4462.
10. Altare, F., Lammas, D., Revy, P., Jouanguy, E., Doffinger, R., Lamhamedi, S., Drysdale, P., Scheel-Toellner, D., Girdlestone, J., Darbyshire, P., Wadhwa, M., Dockrell, H., Salmon, M., Fischer, A., Durandy, A., Casanova, J. L., and Kumararane, D. S. (1998). Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J. Clin. Invest. 102, 2035-2040.
11. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer, Williams, M. G., Bell, J. I., McMichael, A. J., and Davis, M. M. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96.
12. Apostolou, I., Takahama, Y., Belmant, C., Kawano, T., Huerre, M., Marchal, G., Cui, J., Taniguchi, M., Nakauchi, H., Fournie, J. J., Kourilsky, P., and Gachelin, G. (1999). Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA 96, 5141-5146.
13. Armstrong, J. A., and Hart, P. D. (1975). Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142, 1-16.
14. Arnold, D., Faath, S., Rammensee, H., and Schild, H. (1995). Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182, 885-889.
15. Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchinco, M. E., Jansson, M., Zawaiden, S., Rittling, S. R., Denhardt, D. T., Gliwicker, M. J., and Cantor, H. (2000). Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287, 860-864.
16. Ashley, R. V., and Murray, C. J. L. (1996). Economic perspective on vaccine needs. In "Concepts in Vaccine Development" (S. H. E. Kaumann, ed.), pp. 27-70, Walter de Gruyter, Berlin, New York.
17. Bacon, J. A., Burrows, T. W., and Yates, M. (1950). The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants. Br. J. 31, 714-724.
18. Baldwin, S. L., D'Souza, C., Roberts, A. D., Kelly, B. P., Frank, A. A., Lui, M. A., Ulmer, JB, Huygen, K., McMurray, D. M., and Orme, I. M. (1998). Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Inf. Immun. 66, 2951-2959.
19. Balk, S. P., Ebert, E. C., Blumenthal, R. L., McDermott, F. V., Wucherpfennig, K. W., Landau, S. B., and Blumberg, R. S. (1991). Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science 253, 1411-1415.
20. Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
21. Bansal, P., Mukherjee, P., Basu, S.K., George, A., Bal, V., and Rath, S. (1999). MHC class I-restricted presentation of maleylated protein binding to scavenger receptors. J. Immunol. 162, 4430-4437.
22. Barry, M. A., Lai, W. C., and Johnston, S.A. (1995). Protection against mycoplasma infection using expression-library immunization. Nature 377, 632-635.
23. Bauer, A., Huttinger, R., Staffler, G., Hansmann, C., Schmidt, W., Majdic, O., Knapp, W., and Stockinger, H. (1997). Analysis of the requirement for beta 2-microglobulin for expression and formation of human CD1 antigens. Eur. J. Immunol. 27, 1366-1373.
24. Beckman, E. M., Melian, A. M., Behar, S. M., Sieling, P. A., Chatterjee, D., Matsumoto, R., Rosat, J.-P., Modlin, R. L., and Porcelli, S. A. (1996). CD1c restricts responses of mycobacteria-specific T cells: Evidence for antigen presentation by a second member of the human CD1 family. J. Immunol. 157, 2803.
25. + T cells. Nature 372, 691-694.
26. Behar, S. M., Dascher, C. C., Grusby, M. J., Wang, C.-R., and Brenner, M. B. (1999). Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189, 1973-1980.
27. Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., and Small, P. M. (1999). Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284, 1520-1523.
28. Bellone, M., Iezzi, G., Rovere, P., Galati, G., Rochetti, A., Pia Protti, M., Davoust, J., Rugarli, C., and Manfredi, A. A. (1997). Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159, 5391-5399.
29. Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R., and Brutkiewicz, R. R. (1995). CD1 recognition by mouse NK1+T lymphocytes. Science 268, 863-865.
30. Berche, P., Gaillard, J. L., and Sansonetti, P. J. (1987). Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J. Immunol. 138, 2266-2271.
31. Berin, M. C., McKay, D. M., and Perdue, M. H. (1999). Immune-epithelial interactions in host defense. Am. J. Trop. Med. Hygiene 60, 16-25.
32. Bermudez, L. E., and Kaplan, G. (1995). Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol. 3, 22-27.
33. Berthet, F. X., Lagranderie, M., Gounon, P., Laurent-Winter, C., Ensergueix, D., Chavarot, P., Thouron, F., Maranghi, E., Pelicic, V., Portnoi, D., Marchal, G., and Gicquel, B. (1998). Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 282, 759-762.
34. Beyers, A. D., van Rie, A., Adams, J., Fenhalls, G., Gie, R., and Beyers, N. (1998). Signals that regulate the host response to Mycobacterium tuberculosis. Novartis Foundation Symposium 217, 145-157.
35. Bielecki, J., Youngman, P., Connelly, P., and Portnoy, D. A. (1990). Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 345, 175-176.
36. Blachere, N. E., Li, Z., Chandawarkar, R. Y., Suto, R., Jaikaria, N. S., Basu, S., Udono, H., and Srivastava, P. K. (1997). Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186, 1315-1322.
37. Blackstock, W. P., and Weir, M. P. (1999). Proteomics: Quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17, 121-127.
38. Bland, P. W., and Warren, L. G. (1986). Antigen presentation by epithelial cells of the rat small intestine. 1. Kintetics, antigen-specificity, and blocking by anti-Ia antisera. Immunology 58, 1-7.
39. Böhm, W., Mertens, T., Schirmbeck, R., and Reimann, J. (1998). Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 16, 949-954.
40. Bouwer, H. G., Nelson, C. S., Gibbins, B. L., Portnoy, D. A., and Hinrichs, D. J. (1992). Listeriolysin O is a target of the immune response to Listeria monocytogenes. J. Exp. Med. 175, 1467-1471.
41. Brandtzaeg, P., Baekkevold, E. S., Farstad, I. N., Jahnsen, F. L., Johansen, F.-E., Nilsen, E. M., and Yamanaka, T. (1999). Regional specialization in the mucosal immune system: What happens in the microcompartments. Immunol. Today 20, 141-151.
42. Brennan, P. J., and Nikaido, H. (1995). The envelope of mycobacteria. Ann. Rev. Biochem. 64, 29-63.
43. Bretscher, P. A. (1992). A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol. Today 13, 342-345.
44. Brightbill, H. D., Libraty, D. H., Krutzki, S. R., Yang, R.-B., Belisle, J. T., Bleharski, J. R., Maitland, M., Norgard, M. V., Plevy, S. E., Smale, S. T., Brennan, P. J., Bloom, B. R., Godowski, P. J., and Modlin, R. L. (1999). Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732-736.
45. Brutkiewicz, R. R., Bennink, J. R., Yewdell, J. W., and Bendelac, A. (1995). TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182, 1913-1919.
46. Buchmeier, N. A., and Heffron, F. (1991). Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium. Inf. Immun. 59, 2232-2238.
47. Busch, D. H., Pilip, I. M., Vijh, S., and Pamer, E. G. (1998). Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 8, 353-362.
48. Calmette, A., Guerin, C., Negre, L., and Bocquet, A. (1927). Sur la vaccination préventive des enfants nouveau-nés contre la tuberculose par le BCG. Ann. Inst. Pasteur 3, 201.
49. Carbone, F. R., and Gleeson, P. A. (1997). Carbohydrates and antigen recognition by T cells. Glycobiology 7, 725-730.
50. Cardenas, L., and Clements, J. D. (1993). Stability, immunogenicity, and expression of foreign antigens in bacterial vaccine vectors. Vaccine 11, 126-135.
51. Carson, D. A., and Raz, E. (1997). Oligonucleotide adjuvants for T helper 1 (Thl)-specific vaccination. J. Exp. Med. 186, 1621-1622.
52. Casadevall, A., and Pirofski, L.-A. (1999). Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity. Inf. Immun. 67, 3703-3713.
53. Catic, A., Dietrich, G., Gentschev, I., Goebel, W., Kaufmann, S. H. E., and Hess, J. (1999). Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into major histocompatibility complex class I presentation pathway of macrophages. Microbes Inf. 1, 113-121.
54. Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M., and Cowdery, J. S. (1997). Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84, 185-193.
55. Chan, J., Xing, Y., Magliozzo, R. S., and Bloom, B. R. (1992). Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175, 1111-1122.
56. Chen, Y. H., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V. K., and Weiner, H. L. (1995). Peripheral deletion of antigen-reactive T-cells in oral tolerance. Nature 376, 177-180.
57. Chien, Y.-H., Jores, R., and Crowley, M. P. (1996). Recognition by γ/δ T cells. Annu. Rev. Immunol. 14, 511-532.
58. Chu, R. S., Askew, D., Noss, E. H., Tobian, A., Krieg, A. M., and Harding, C. V. (1999). CpG oligonucleotides down-regulate macrophage class II MHC antigen processing. J. Immunol. 163, 1188-1194.
59. Chugh, I. B., and Khuller, G. K. (1993). Immunoprotective behaviour of liposome entrapped cell wall subunit of Mycobacterium tuberculosis against experimental tuberclous infection in mice. Eur. Resp. J. 6, 811-815.
60. Colditz, G. A., Brewer, T. F., Berkey, C. S., Wilson, M. E., Burdick, E., Fineberg, H. V., and Mosteller, F. (1994). Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J. Am. Med. Assoc. 271, 698-702.
61. Cole, S. T. (1999). Learning from the genome sequence of Mycobacterium tuberculosis H37Rv. FEBS Lett. 452, 7-10.
62. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., Tekaia, F., Badcock, K., Basham, D., Brown, D., Chillingworth, T., Connor, R., Davies, R., Devlin, K., Feltwell, T., Gentles, S., Hamlin, N., Holroyd, S., Hornsby, T., Jagels, K., and Barrell, B. G. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
63. Collins, H. L., Schaible, U. E., Ernst, J. D., and Russell, D. G. (1997). Transfer of phagocytosed particles to the parasitophorous vacuole of Leishmania mexicana is a transient phenomenon preceding the acquisition of annexin I by the phagosome. J. Cell Sci. 110, 191-200.
64. Committee to Study Priorities for Vaccine Development, I. o. M. (1999). Vaccines for the 21st century: A tool for decision-making (prepublication copy, uncorrected proof), http:// bob.nap.edu/readingroom/books/vacc21/.
65. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., and Falo, L. D., Jr. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nature Medicine 2, 1122-1128.
66. Connell, N. D., Medina-Acosta, E., McMaster, W. R., Bloom, B. R., and Russell, D. G. (1993). Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc Natl. Acad. Sci. USA 90, 11473-11477.
67. Conradt, P., Hess, J., and Kaufmann, S. H. E. (1999). Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin. Microbes Inf. 1, 753-764.
68. Constant, P., Davodeau, F., Peyrat, M.-A., Poquet, Y., Puzo, G., Bonneville, M., and Fournié, J.-J. (1994). Stimulation of human γδT cells by nonpeptidic mycobacterial ligands. Science 264, 267-270.
69. Cooney, E. L., Collier, A. C., Greenberg, P. D., Coombs, K. W., Zarling, J., Arditti, D. E., Hoffman, M. C., Hu, S. L., and Corey, L. (1991). Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 337, 567-572.
70. Cooper, A. M., Magram, J., Ferrante, J., and Orme, I. M. (1997). Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186, 39-45.
71. Cooper, A. M., Roberts, A. D., Rhoades, E. R., Callahan, J. E., Getzy, D. M., and Orme, I. M. ( 1995). The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84, 423-432.
72. Cornell, K. A., Bouwer, H. G. A., Hinrichs, D. J., and Barry, R. A. (1999). Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O. J. Immunol 163, 322-329.
73. Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. (1996). Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J, Exp. Med. 184, 1555-1560.
74. Cossart, P. (1997). Host/pathogen interactions. Subversion of the mammalian cell cytoskeleton by invasive bacteria. J, Clin. Invest. 99, 2307-2311.
75. Crowle, A. J. (1988). Immunization against tuberculosis-what kind of vaccine. Inf. Immun. 56, 2769-2773.
76. D'Souza, C., Cooper, A. M., Frank, A. A., Mazzaccaro, R. J., Bloom, B. B., and Orme, I. M. (1997). An anti-inflammatory role for γδ lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 158, 1217-1221.
77. Darji, A., Guzman, C. A., Gerstel, B., Wachholz, P., Timmis, K. N., Wehland, J., Chakraborty, T., and Weiss, S. (1997). Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 91, 765-775.
78. Davis, B. D., Dulbecco. R., Eisen, H. N., and Ginsberg, H. S. (1969). "Microbiology," pp. 603-652. Harper International, Cambridge, MA.
79. Davis, H. L., McCluskie, M. J., Cerin, J. L., and Purcell, R. H. (1996). DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. USA 93, 7213-7218.
80. de Jong, R., Altare, F., Haagen, I. A., Elferink, D. G., Boer, T., van, B., Vriesman, P. J., Kabel, P. J., Draaisma, J. M., van Dissel, J. T., Kroon, F. P., Casanova, JL, and Ottenhoff, T. H. (1998). Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435-1438.
81. DeLibero, G., Casorati, G., Giachino, C., Carbonara, C., Migone, N., Matzinger, P., and Lanzavėcchia, A. ( 1991). Selection by two powerful antigens may account for the presence of the major population of human peripheral γ/δ T cells. J. Exp. Med. 173, 1311-1322.
82. + T cell lines. Eur. J. Immunol. 18, 59-66.
83. Demangel, C., Bean, A. G. D., Feng, C. G., Kamath, A. T., and Britton, W. J. (1999). Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells. Eur. J. Immunol. 29, 1972-1979.
84. Denis, O., Tanghe, A., Palfiet, K., Jurion, F., van den Berg, T. P., Vanonckelen, Ooms, J., Saman, E., Ulmer, J. B., Content, J., and Huygen, K. (1998). Vaccination with plasmid DNA encoding myocobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Inf. Immun. 66, 1527-1533.
85. Dietrich, G., Bubert, A., Gentschev, I., Sokolovic, Z., Simm, A., Catic, A., Kaufmann, S. H., Hess, J., Szalay, A. A., and Goebel, W. (1998). Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogene. Nature Biotechnol. 16, 181-185.
86. Dietrich, G., Gentschev, I., Hess, J., Ulmer, J. B., Kaufmann, S. H. E., and Goebel, W. (1999). Delivery of DNA vaccines by attenuated intracellular bacteria. Immunol. Today 20, 251-253.
87. Dillon, D. C. (1999). Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Inf. Immun. 67, 2941-2950.
88. Donnelly, J. J., Ulmer, J. B., and Liu, M. A. (1994). Immunization with DNA. J. Immunol. Meth. 176, 145-152.
89. Dunbar, P. R., Ogg, G. S., Chen, J., Rust, N., van der Bruggen, P., and Cerundolo, V. (1998). Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8, 413-416.
90. Duncan, D. D., and Swain, S. L. (1994). Role of antigen-presenting cells in the polarized development of helper T-cells subsets-evidence for differential cytocine production by tho cells in response to antigen presentation by B-cells and macrophages. Eur. J. Immunol. 24, 2506-2514.
91. Dutton, R. W., Bradley, L. M., and Swain, S. L. (1998). T cell memory. Annu. Rev. Immunol. 16, 201-223.
92. Edelman, R., Palmer, K., Russ, K. G., Secrest, H. P., Becker, J. A., Bodison, S. A., Perry, J. G., Sills, A. R., Barbour, A. G., Luke, C. J., Hanson, M. S., Stover, C. K., Burlein, J. E., Bansal, G. P., Connor, E. M., and Koenig, S. (1999). Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: A candidate Lyme disease vaccine. Vaccine 17, 904-914.
93. Edelson, B. T., Cossart, P., and Unanue, E. R. (1999). Paradigm revisited: Antibody provides resistance to Listeria infection. J. Immunol. 163, 4087-4090.
94. Edwards, M. F., and Stocker, B. A. (1988). Construction of delta aroA his delta pur strains of Salmonella typhi. J. Bacteriol. 170, 3991-3995.
95. Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., and Klinman, D. M. (1999). Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162, 2291-2298.
96. Ellis, R. W. (1999). New technologies for making vaccines. Vaccine 17, 1596-1604.
97. Engering, A. J., Cella, M., Fluitsma, D., Brockhaus, M., Hoefsmit, E. C., Lanzavecchia, A., and Pieters, J. (1997). The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27, 2417-2425.
98. Erdile, L. F., Brandt, M. A., Warakomski, D. J., Westrack, G. J., Sadziene, A., Barbour, A. G., and Mays, J. P. (1993). Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Inf. Immun. 61, 81-90.
99. Etchart, N., Buckland, R., Liu, M. A., Wild, T. F., and Kalserlian, D. (1997). Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78, 1577-1580.
100. Euzeby, J. P. (1999). Revised Salmonella nomenclature: Designation of Salmonella enterica (ex Kauffmann and Edwards, 1952), Le Minor and Popoff, 1987 sp. nov., nom. rev. as the neotype species of the genus Salmonella Lignieres 1900 (Approved Lists 1980), rejection of the name Salmonella choleraesuis (Smith, 1894) Weldin, 1927 (Approved Lists 1980), and conservation of the name Salmonella typhi (Schroeter, 1886) Warren and Scott, 1930 (Approved Lists 1980). Request for an Opinion. Intl. J. System. Bacteriol. 49, 927-930.
101. Exley, M., Garcia, J., Balk, S. P., and Porcelli, S. (1997). Requirements for CDld recognition by human invariant V alpha 24( + ) CD4(-)CD8(-) T cells. J. Exp. Med. 186, 109-120.
102. Fang, F. C. (1997). Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 100, S43-S50.
103. Farstad, I. N., Halstensen, T. S., Fausa, O., and Brandtzaeg, P. (1994). Heterogeneity of M-cell-associated B and T cells in human Peyer's patches. Immunology 83, 457-464.
104. Fennelly, G. J., Khan, S. A., Abadi, M. A., Wild, T. F., and Bloom, B. R. (1999). Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol. 162, 1603-1610.
105. Fensterle, J., Grode, L., Hess, J., and Kaufmann, S. H. E. (1999). Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun. J. Immunol. 163, 4510-4518.
106. Ferreccio, C., Levine, M. M., Rodriguez, H., and Contreras, R. (1989). Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: A field trial in an endemic area. J. Infect. Dis. 159, 766-769.
107. Ferru, I., Rollin, C., Estaquier, J., Sutton, P., Delacre, M., Tartar, A., Gras-Masse, H., and Auriault, C. (1996). Comparison of the immune response elicited by a free peptide and a lipopeptide construct. Peptide Res. 9, 136-143.
108. Fischer Lindahl, K., Byers, D. E., Dahi, V. M., Hovik, R., Jones, E. P., Smith, G. P., Wang, C.-R., Xiao, H., and Yoshino, M. (1997). H2-M3, a full-service class lb histocompatibility antigen. Annu. Rev. Immunol. 15, 851-879.
109. Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkness, E. F., Kerlavage, A. R., Bult, C. J., Tomb, J. F., Dougherty, B. A., and Merrick, J. M. (1995). Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496-512.
110. Flesch, I. E., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., and Kaufmann, S. H. (1995). Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 181, 1615-1621.
111. Flesch, I. E. A., and Kaufmann, S. H. E. (1991). Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: Role of reactive nitrogen intermediates. Infect. Immun. 59, 3213-3218.
112. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B., and Bloom, B. R. (1992). Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89, 12013-12017.
113. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Sypek, J., Wolf, S., and Bloom, B. R. (1995). IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155, 2515-2524.
114. Flynn, J. L., Weiss, W. R., Norris, K. A., Seifert, H. S., Kumar, S., and So, M. (1990). Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol. Microbiol. 4, 2111-2118.
115. Frankel, F. R., Hegde, S., Lieberman, J., and Paterson, Y. (1995). Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria, monocytogenes as a live vaccine vector. J. Immunol. 155, 4775-4782.
116. Freitas, A. A., and Rocha, B. (1999). Peripheral T cell survival. Curr. Opin. Immunol. 11, 152-156.
117. Fu, Y., and Galan, J. E. (1998). The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton. Mol. Microbiol. 27, 359-368.
118. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1993). DNA vaccines: Protective immunizations by parenteral, mucosal, and genegun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482.
119. Gaillard, J. L., Berche, P., Mounier, J., Richard, S., and Sansonetti, P. (1987). In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect. Immun. 55, 2822-2829.
120. Garcia, V. E., Sieling, P. A., Gong, J., Barnes, P. F., Uyemura, K., Tanaka, Y., Bloom, B. R. Morita, C. T., and Modlin, R. L. (1997). Single-cell cytokine analysis of γδ T cell responses to nonpeptide mycobacterial antigens. J. Immunol. 159, 1328-1335.
121. Geginat, G. (1999). Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua. J. Immunol. 162, 4781-4789.
122. Gentschev, I., Dietrich, G., Mollenkopf, H. J., Sokolovic, Z., Hess, J., Kaufmann, S. H., and Goebel, W. (1997). The Escherichia coli hemolysin secretion apparatus - A versatile antigen delivery system in attenuated Salmonella. Behring Institute Mitteilungen 98, 103-113.
123. Gentschev, L, Glaser, L, Goebel, W., McKeever, D. J., Musoke, A., and Heussler, V. T. (1998). Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: Secretion of the product enhances specific antibody responses in cattle. Infect. Immun. 66, 2060-2064.
124. Gentschev, L, Hess, J., and Goebel, W. (1990). Change in the cellular localization of alkaline phosphatase by alteration of its carboxy-terminal sequence. Mol. Gen. Genet. 222, 211-216.
125. Gentschev, L, Mollenkopf, H., Sokolovic, Z., Hess, J., Kaufmann, S. H., and Goebel. (1996). Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene 179, 133-140.
126. Gentschev, L, Sokolovic, Z., Mollenkopf, H. J., Hess, J., Kaufmann, S. H., Kuhn, M., Krohne, G. F., and Goebel, W. (1995). Salmonella strain secreting active listeriolysin changes its intracellular localization. Infect. Immun. 63, 4202-4205.
127. Germanier, R., and Fuer, E. (1975). Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: A candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131, 553-558.
128. Gheorghiu, M., Lagranderie, M. R., Gicquel, B. M., and Leclerc, C. D. (1994). Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen. Infect. Immun. 62, 4287-4295.
129. Goebel, W., and Kreft, J., (1997). Cytolysins and the intracellular life of bacteria. Trends Microbiol. 5, 86-88.
130. Gomes, M. S., Paul, S., Moreira, A. L., Appelberg, R., Rabinovitch, M., and Kaplan, G. (1999). Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect. Immun. 67, 3199-3206.
131. Gonzalez, C., Hone, D., Noriega, F. R., Tacket, C. O., Davis, J. R., Losonsky, G., Nataro, J. P., Hoffman, S., Malik, A., and Nardin, E. (1994). Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodiumfalciparum: strain construction and safety and immunogenicity in humans. J. Infect. Dis. 169, 927-931.
132. Gottlieb, S., McLaughlin, F. X., Levine, L., Latham, W. C., and Edsall, G. (1964). Longterm immunity to tetanus - A statistical evaluation and its clinical implication. Am. J. Public Health 54, 961-971.
133. Grützkau, A., Hanski, C., Hahn, H., and Riecken, E. O. (1990). Involvement of M cells in the bacterial invasion of Peyer's patches: A common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31, 1011-1015.
134. Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D. M., and Courvalin, P. (1998). Functional gene transfer from intracellular bacteria to mammalian cells. Nature Biotechnol. 16, 862-866.
135. Guler, M. L., Gorham, J. D., Hsieh, C. S., Mackey, A. J., Steen, R. G., Dietrich, W. F., and Murphy, K. M. (1996). Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271, 984-987.
136. Guleria, I., Teitelbaum, R., McAdam, R. A., Kalpana, G., Jacobs, W. R. J., and Bloom, B. R. (1996). Auxotrophic vaccines for tuberculosis. Nature Med. 2, 334-337.
137. Gurunathan, S., Prussin, C., Sacks, D. L., and Seder, R. A. (1998). Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nature Med. 4,1409-1415.
138. Guzman, C. A., Rohde, M., Chakraborty, T., Domann, E., Hudel, M., Wehland, J., and Timmis, K. N. (1995). Interaction of Listeria monocytogenes with mouse dendritic cells. Infect. Immun. 63, 3665-3673.
139. Hara, T., Mizuno, Y., Takaki, K., Takada, H., Akeda, H., Aoki, T., Nagata, M., Ueda, K., Matsuzaki, G., Yoshikai, Y. et al. (1992). Predominant activation and expansion of Vγ9-bearing γδT cells in vivo as well as in vitro in Salmonella infection. J. Clin. Invest. 90, 204-210.
140. Harding, C. V., and Pfeifer, J. D. (1994). Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells. Immunology 83, 670-674.
141. Harding, C. V., Song, R., Griffin, J., France, J., Wick, M. J., Pfeifer, J. D., and Geuze, H. J. (1995). Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes. Infect. Agents Disease 4, 1-12.
142. Harty, J. T., and Bevan, M. J. (1992). CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175, 1531-1538.
143. Hayashi, T., Catanzaro, A., and Rao, S. P. (1997). Apoptosis of human monocytes and macrophages by Mycobacterium avium sonicate. Infect. Immun. 65, 5262-5271.
144. Heithoff, D. M., Sinsheimer, K. L., Low, D. A., and Mahan, M. J. (1999). An essential role for DNA adenine methylation in bacterial virulence. Science 284, 967-970.
145. Hershberg, K. M., Framson, P. E., Cho, D. H., Lee, L. Y., Kovats, S., Beitz, J., Blum, J. S., and Nepom, G. T. (1997). Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J. Clin. Invest. 100, 204-215.
146. Hess, J., Dietrich, G., Gentschev, I., Miko, D., Goebel, W., and Kaufmann, S. H. (1997). Protection against murine Iisteriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen Superoxide dismutase. Infect. Immun. 65, 1286-1292.
147. Hess, J., Dreher, A., Gentschev, I., Goebel, W., Ladel, C., Miko, D., and Kaufmann, S. H. (1996a). Protein p60 participates in intestinal host invasion by Listeria monocytogenes. Zentralblattfuer Bakteriologie 284, 263-272.
148. Hess, J., Gentschev, I., Goebel, W., and Jarchau, T. (1990). Analysis of the haemolysin secretion system by PhoA-HlyA fusion proteins. Mol. Gen. Genetics 224, 201-208.
149. Hess, J., Gentschev, I., Miko, D., Welzel, M., Ladel, C., Goebel, W., and Kaufmann, S. H. (1996b). Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93, 1458-1463.
150. Hess, J., Gentschev, I., Szalay, G., Ladel, C., Bubert, A., Goebel, W., and Kaufmann, S. H. (1995). Listeria monocytogenes p60 supports host cell invasion by and in vivo survival of attenuated Salmonella typhimurium. Infect. Immun. 63, 2047-2053.
151. Hess, J., Grode, L., Hellwig, J., Gentschev, L, Goebel, W., Ladel, C. H., and Kaufmann, S. H. E. (1999). Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30 kDa-antigen of Mycobacterium bovis BCG. FEMS Immunol. Med. Microbiol., in press.
152. Hess, J., and Kaufmann, S. H. E. (1997). Principles of cell-mediated immunity underlying vaccination strategies against intracellular pathogens. In "Host Response to Intracellular Pathogens" (S. H. E. Kaufmann, ed.), pp. 75-94. R.G. Landes Company, Austin.
153. Hess, J., Miko, D., Catic, A., Lehmensiek, V., Russell, D. G., and Kaufmann, S. H. (1998). Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 95, 5299-5304.
154. Higgins, D. E., Shastri, N., Portnoy, D. A., and Portnoy. (1999). Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Mol. Microbiol. 31, 1631-1641.
155. Hiromatsu, K., Yoshikai, Y., Matsuzaki, G., Ohga, S., Muramori, K., Matsumoto, K., Bluestone, J. A., and Nomoto, K. (1992). A protective role of γδ cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175, 49-56.
156. Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., and Ezekowitz, R. A. (1999). Phylogenetic perspectives in innate immunity. Science 284, 1313-1318.
157. Hoffman, S. L., Rogers, W. O., Carucci, D. J., and Venter, J. C. (1998). From genomics to vaccines: Malaria as a model system. Nature Med. 4, 1351-1353.
158. Hohmann, E. L., Oletta, C. A., Killeen, K. P., and Miller, S. I. (1996). phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Diseases 173, 1408-1414.
159. Hohmann, E. L., Oletta, C. A., and Miller, S. I. (1996). Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14, 19-24.
160. Hoiseth, S. K., and Stocker, B. A. (1981). Aromatic-dependent Salmonella typhimurium are nonvirulent and effective as live vaccines. Nature 291, 238-239.
161. Honda, M., Matsuo, K., Nakasone, T., Okamoto, Y., Yoshizaki, H., Kitamura, K., Sugiura, W., Watanabe, K., Fukushima, Y., and Haga, S. (1995). Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals. Proc. Natl. Acad. Sci. USA 92, 10693-10697.
162. Hone, D. M., Attridge, S. R., Forrest, B., Morona, R., Daniels, D., LaBrooy, J. T., Bartholomeusz, R. C., Shearman, D. J., and Hackett, J. (1988). A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect. Immun. 56, 1326-1333.
163. Hone, D. M., Harris, A. M., Chatfield, S., Dougan, G., and Levine, M. M. (1991). Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9, 810-816.
164. Hone, D. M., Shata, M. T., and Pascual, D. W. L. G. K. (1999). Mucosal vaccination with Salmonella vaccine vectors. In "Intracellular Bacterial Vaccine Vectors" (Y. Patterson, ed.), pp. 1-23. John Wiley and Sons.
165. Hormaeche, C. E., and Khan, C. M. A. (1996). Recombinant bacteria as vaccine carriers of heterologous antigens. In "Concepts in Vaccine Development" (S. H. E. Kaufman, ed.), pp. 327-360. Walter de Gruyter, Berlin, New York.
166. Horwitz, M. A., Lee, B. W., Dillon, B. J., and Harth, G. (1995). Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92, 1530-1534.
167. Hsieh, B., Schrenzel, M. D., Mulvania, T., Lepper, H. D., DiMolfetto-Landon, L., and Ferrick, D. A. (1996). In vivo cytokine production in murine listeriosis. Evidence for immunoregulation by γδ + T cells. J. Immunol. 156, 232-237.
168. Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., and Murphy, K. M. (1993). Development of TH1 CD4+ T cells through IL-12 produced by Listera-induced macrophages. Science 260, 547-549.
169. Huebner, K. E. (1996). BCG vaccination in the control of tuberculosis. Curr. Top. Microbiol. Immunol. 215, 263-282.
170. Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Deck, R. R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., Drowart, A., Lozes, E., Vandenbussche, P., Van Vooren, J. P., Liu, M. A., and Ulmer, J. B. (1996). Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. 2, 893-898.
171. Ikonomidis, G., Portnoy, D. A., Gerhard, W., and Paterson, Y. (1997). Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines. Vaccine 15, 433-440.
172. Inaba, K., Inaba, M., Naito, M., and Steinman, K. M. (1993). Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178, 479-488.
173. Ishii, T., Udono, H., Yamano, T., Ohta, H., Uenaka, A., Ono, T., Hizuta, A., Tanaka, N., Srivastava, P. K., and Nakayama, E. (1999). Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J. Immunol. 162, 1303-1309.
174. Jenner, E. (1798). An inquiry into the causes and effects of the Variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the Cow-Pox, p. 75 with 4 plates, London, UK.
175. Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M., and Nussenzweig, M. C. (1995). The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151-155.
176. Johansson, M., Ward, M., and Lycke, N. (1997). B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis. Immunology 92, 422-428.
177. Johnston, S. A. (1998). DNA vaccines and related technology. Talk held at the International Symposium on Vaccinology (18-20. Nov., 1998) in Paris.
178. Jondal, M., Schirmbeck, R., and Reimann, J. (1996). MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302.
179. Jones, B. D., Ghori, N., and Falkow, S. (1994). Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 180, 15-23.
180. Jones, S., and Portnoy, D. A. (1994). Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O. Infect. Immun. 62, 5608-5613.
181. Jones, S., Preiter, K., and Portnoy, D. A. (1996). Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen. Mol. Microbiol. 21, 1219-1225.
182. Joyce, S., Woods, A. S., Yewdell, J. W., Bennink, J. K., Desilva, A. D., Boesteanu, A., Balk, S. P., Cotter, K. J., and Brutkiewicz, K. K. (1998). Natural ligand of mouse CD1d1-ceHular glycosylphosphatidylinositol. Science 279, 1541-1544.
183. Jungblut, P., Schaible, U., Mollenkopf, H.-J., Zimny-Arndt, U., Raupach, B., Mattow, J., Halada, P., Lamer, S., Hagens, K., and Kaufmann, S. H. E. (1999). Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: Towards functional genomics of microbial pathogens. Mol. Microbiol. 33, 1103-1117.
184. + T cells to Mycobacterium tuberculosis is restricted to Vγ 9-bearing cells. J. Exp. Med. 173, 1331-1338.
185. Kaiserlian, D., Vidal, K., and Revillard, J. P. (1989). Murine enterocytes can present solubleantigen to specific class-II-restricted CD4+ T-cells. Eur. J. Immunol. 19, 1513-1516.
186. Kalman, S., Mitchell, W., Marathe, R., Lammel, C., Fan, J., Hyman, R. W., Olinger, Grimwood, J., Davis, R. W., and Stephens, R. S. (1999). Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21, 385-389.
187. Kamath, A. T., Feng, C. G., Macdonald, M., Briscoe, H., and Britton, W. J. (1999). Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 67, 1702-1707.
188. Kameoka, M., Nishino, Y., Matsuo, K., Ohara, N., Kimura, T., Yamazaki, A., Yamada, T., and Ikuta, K. (1994). Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 12, 153-158.
189. Kaniga, K., Uralil, J., Bliska, J. B., and Galan, J. E. (1996). A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 21, 633-641.
190. Kaufmann, S. H. E. (1988a). Listeriosis: New findings - current concern. Microb. Pathogen. 5, 225-231.
191. Kaufmann, S. H. E. (1988b). CD8+ T lymphocytes in intracellular microbial infections. Immunol. Today 9, 168-174.
192. Kaufmann, S. H. E. (1991). Heat-shock proteins and pathogenesis of bacterial infections. Springer Semin. Immunpathol. 13, 25-36.
193. Kaufmann, S. H. E. (1993). Immunity to intracellular bacteria. Annu. Rev. Immunol. 11, 129-163.
194. Kaufmann, S. H. E. (1996). Gamma/delta and other unconventional T lymphocytes: What do they see and what do they do? Proc. Natl. Acad. Sci. USA 93, 2272-2279.
195. Kaufmann, S. H. E. (1999). Killing vs suicide in antibacterial defence. Trends Microbiol. 7, 59-61.
196. Kaufmann, S. H. E., and Andersen, P. (1998). Immunity to mycobacteria with emphasis on tuberculosis: Implications for rational design of an effective tuberculosis vaccine. Chem. Immunol. 70, 21-59.
197. Kaufmann, S. H. E. and Ladel, C. H. (1994). Role of T cell subsets in immunity against intracellular bacteria: Experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology 191, 509-519.
198. Kaufmann, S. H. E. (1998). Immunity to intracellular bacteria. In "Fundamental Immunology" (W. Paul, ed.), 4th edition, pp. 1335-1371. Raven Press Ltd., New York.
199. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H., and Taniguchi, M. (1997). CD1d-restricted and TCR-mediated activation of Vα 14 NKT cells by glycosylceramides. Science 278, 1626-1629.
200. Keitel, W. A., Bond, N. L., Zahradnik, J. M., Cramton, T. A., and Robbins, J. B. (1994). Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 12, 195-199.
201. Kerksiek, K. M., Busch, D. H., Plip, I. M., Allen, S. E., and Pamer, E. G. (1999). H2-M3 restricted T cells in bacterial infection: Rapid primary but diminished memory responses. J. Exp. Med. 190, 195-204.
202. Kerneis, S., Bogdanova, A., Kraehenbuhl, J. P., and Pringault, E. (1997). Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277, 949-952.
203. Killeen, K., Spriggs, D., and Mekalanos, J. (1999). Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm. Curr. Top. Microbiol. Immunol. 236, 237-254.
204. Kim, J. J., Nottingham, L. K., Wilson, D. M., Bagarazzi, M. L., Tsai, A., Morrison, L. D., Javachan, A., Chalian, A. A., Agadjanyan, M. G., and Weiner, D. B. (1998). Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes. Vaccine 16, 1828-1835.
205. Kjeldsen, K., and Heron, I. S. O. (1985). Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet 1, 900-902.
206. Klavinskis, L. S., Barnfield, C., Gao, L., and Parker, S. (1999). Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J. Immunol. 162, 254-262.
207. Klinman, D. M., Yamshchikov, G., and Ishigatsubo, Y. (1997). Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158, 3635-3639.
208. Kohbata, S., Yokoyama, H., and Yabuuchi, E. (1986). Cytopathogenic effect of Salmonella typhi-GIFU 100007 on M cells of murine ileal Peyer's patches in ligated ileal loops: An ultrastructural study. Microbiol. Immunol. 30, 1225-1237.
209. Kolle, W., and von Wassermann, A. (1912). Handbuch der pathogenen Mikroorganismen, pp. 555-631. Gustav Fuscher Verlag Jena.
210. Kouacsovics-Bankowski, M., and Rock, K. L. (1995). A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-246.
211. Kremer, L., Dupre, L., Riveau, G., Capron, A., and Locht, C. (1998). Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-transferase from Schistosoma haematobium. Infect. Immun. 66, 5669-5676.
212. Kremer, L., Riveau, G., Baulard, A., Capron, A., and Locht, C. (1996). Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione S-transferase. J. Immunol. 156, 4309-4317.
213. Krieg, A. M., Love-Homan, L., Yi, A. K., and Harty, J. T. (1998). CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161, 2428-2434.
214. Kuhn, M., and Goebel, W. (1989). Identification of an extracellular protein of Listeria monocytogenes possibly involved in intracellular uptake by mammalian cells. Infect. Immun. 57, 55-61.
215. Kuklin, N., Daheshia, M., Karem, K., Manickan, E., and Rouse, B. T. (1997). Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol 71, 3138-3145.
216. Kumagai, K. (1922). Über den Resorptionsvergang der corpusculären Bestandteile im Darm. Kekkaku-Zassi 4, 429-431.
217. Kuo, C., and Campbell, L. A. (1998). Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol. Med. Today, 4, 426-430.
218. Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., and Kaufmann, S. H. (1995). Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis [published erratum appars in Eur. J. Immunol. 1995 Dec: 25 (12): 3525]. Eur. J. Immunol. 25, 2877-2881.
219. Ladel, C. H., Flesch, I. E., Arnoldi, J., and Kaufmann, S. H. (1994). Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria, monocytogenes infection [published erratum appears in J. Immunol. 1995 Apr 15; 154 (8): 4223]. J. Immunol. 153, 3116-3122.
220. Lalvani, A., Brookes, R., Wilkinson, K. J., Malin, A. S., Pathan, A. A., Andersen, P., Dockrell, H., Pasvol, G., and Hill, A. V. (1998). Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95, 270-275.
221. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C. K., and Koenig, S. (1994a). Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372, 552-555.
222. Langermann, S., Palaszynski, S. R., Burlein, J. E., Koenig, S., Hanson, M. S., Briles, D. E., and Stover, C. K. (1994b). Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180, 2277-2286.
223. Le Minor, L. (1987). Request for an opinion, designation of Salmonella enterica sp Nov., nom. Rev., as the type and only species of the genus Salmonella. Int. J. System. Bacteriol. 37, 465-468.
224. Levine, M. M., Herrington, D., Murphy, J. R., Morris, J. G., Losonsky, G., Tall, B., Lindberg, A. A., Svenson, S., Baqar, S., and Edwards, M. F. (1987). Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Invest. 79, 888-902.
225. Li, Y., Yio, X. Y., and Mayer, L. (1995). Human intestinal epithelial cell-induced CD8(+) T-cell activation is mediated through CD8 and the activation of CD8-associated P 56 (LCK). J. Exp. Med. 182, 1079-1088.
226. Lim, E. M., Lagranderie, M., Le Grand, R., Rauzier, J., Gheorghiu, M., Gicquel, B., and Winter, N. (1997). Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs. AIDS Res. Human Retroviruses 13, 1573-1581.
227. Lindner, R., and Unanue, E. R. (1996). Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15, 6910-6920.
228. Lipford, G. B., Heeg, K., and Wagner, H. (1998). Bacterial DNA as immune cell activator. Trends Microbiol. 6, 496-500.
229. Lipford, G. B., Lehn, N., Bauer, S., Heeg, K., and Wagner, H. (1994a). Theimmunodominant peptide from listeriolysin in Quil A liposomes vaccinates CD8+ cytolytic T cells and confers protection to infection. Immunol. Lett. 40, 101-104.
230. Lipford, G. B., Wagner, H., and Heeg, K. (1994b). Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 12, 73-80.
231. Lowe, D. C., Savidge, T. C., Pickard, D., Eckmann, L., Kagnoff, M. F., Dougan, G., and Chatfield, S. N. (1999). Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA. Infect. Immun. 67, 700-707.
232. Lowrie, D. B., Tascon, R. E., Bonato, V. L. D., Lima, V. M. F., Faccioli, L. H., Stavropoulos, E., Colston, M. J., Hewinsohn, R. G., Moelling, K., and Silva, C. L. (1999). Therapy of tuberculosis in mice by DNA vaccination. Nature 400, 269-271.
233. Lucey, D. R., Clerici, M., and Shearer, G. M. (1996). Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9, 532-562.
234. Mäkelä, P. H., and Hormaeche, C. E. (1997). Immunity to Salmonella. In "Host Response to Intracellular Pathogens" (S. H. E. Kaufmann, ed.), pp. 143-166, R. G. Landes Company, Austin.
235. Macatonia, S. E., Hosken, N. A., Litton, M., Vieira, P., Hsieh, C. S., Culpepper, J. A., Wysocka, M., Trinchieri, G., Murphy, K. M., and O'Gana, A. (1995). Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154, 5071-5079.
236. MacMicking, J, Xie, Q., and Nathan, C. (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
237. 2+ signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J. Exp. Med. 191, 287-302.
238. Manoury, B., Hewitt, E. W., Morrice, N., Dando, P. M., Barrett, A. J., and Watts, C. (1998). An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396, 695-699.
239. Manz, K. A., Lohning, M., Cassese, G., Thiel, A., and Radbruch, A. (1998). Survival of long-lived plasma cells is independent of antigen. Intl. Immunol. 10, 1703-1711.
240. Manz K. A., Thiel, A., and Radbruch, A. (1997). Lifetime of plasma cells in the bone marrow. Nature 388, 133-134.
241. Markiewicz, M. A., Girao, C., Opferman, J. T., Sun, J. L., Hu, Q. H., Agulnik, A. A., Bishop, C. E., Thompson, C. B., and Ashton-Rickardt, P. G. (1998). Long-term T cell memory requires the surface expression of self-peptide major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 95, 3065-3070.
242. Marriott, I., Hammond, T. G., Thomas, E. K., and Bost, K. L. (1999). Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression. Eur. J. Immunol. 29, 1107-1115.
243. Mattingly, J. A., and Waksman, B. H. (1978). Immunological suppression after oral-administration of antigen. 1. Specific suppressor cells formed in rat Peyers patches after oral-administration of sheep erythrocytes and their systemic migration. J. Immunol. 121, 1878-1883.
244. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Kast, W. M., and Deleo, A. B. (1995). Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1, 1297-1302.
245. McCluskie, M. J., and Davis, H. L. (1999). Mucosal immunization with DNA vaccines. Microbes Infect. 1, 685-698.
246. McCune, R. M., and Tompsett, R. M. W. (1957). Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 763-802.
247. McHeyzer-Williams, M. G., and Ahmed, R. (1999). B cell memory and the long-lived plasma cell. Curr. Opin. Immunol. 11, 172-179.
248. McMenamin, C., Pimm, C., McKersey, M., and Holt, P. G. (1994). Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma-delta T-cells. Science 265, 1869-1871.
249. Medina, E., Paglia, P., Nikolaus, T., Muller, A., Hensel, M., and Guzman, C. A. (1999). Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. Infect. Immun. 67, 1093-1099.
250. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B., and Weiner, H. L. (1992). Suppressor T-cells generated by oral tolerization to myelin basic-protein suppress both in vitro and in vivo immune-responses by the release of transforming growth-factor-beta after antigen-specific triggering. Proc. Natl Acad. Sci. USA 89, 421-425.
251. Miller, M. A., Skeen, M. J., and Ziegler, H. K. (1995). Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155, 4817-4828.
252. Miller, M. A., Skeen, M. J., and Ziegler, H. K. (1997). A synthetic peptide administered with IL-12 elicits immunity to Listeria monocytogenes. J. Immunol. 159, 3675-3679.
253. Mittrücker, H. W., Raupach, B., Köhler, A., and Kaufmann, S. H. E. (2000). Role of antibodies in protective immunity against Salmonella typhimurium infection. J. Immunol. 164, 1648-1652.
254. Miyagi, K., Kawakami, K., and Saito, A. (1997). Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect. Immun. 65, 4108-4113.
255. Modlin, R. L., Pirmez, C., Hofman, F. M., Torigian, V., Uyemura, K., Rea, T. H., Bloom, B. R., and Brenner, M. B. (1989). Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature 339, 544-548.
256. Moll, H., Fuchs, H., Blank, C., and Rollinghoff, M. (1993). Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23, 1595-1601.
257. Mombaerts, P., Arnoldi, J., Russ, F., Tonegawa, S., and Kaufmann, S. H. (1993). Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature 365, 53-56.
258. Moody, D. B., Reinhold, B. B., Guy, M. R., Beckman, E. M., Frederique, D. E., Furlong, S. T., Ye, S., Reinhold, V. N., Sieling, P. A., Modlin, R. L., Besra, G. S., and Porcelli, S. A. (1997). Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278, 283-286.
259. Munder, M., Mallo, M., Eichmann, K., and Modolell, M. (1998). Murine macrophages secrete inferferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J. Exp. Med. 187, 2103-2108.
260. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., and Ahmed, R. (1998). Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8, 177-187.
261. Murray, P. J., Aldovini, A., and Young, R. A. (1996). Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc. Natl. Acad. Sci. USA 93, 934-939.
262. Noll, A., Bucheler, N., Bohn, E., and Autenrieth, I. B. (1997). Microbial heat shock proteins as vaccine. Behring Institute Mitteilungen 98, 87-98.
263. Noll, A., Bucheler, N., Bohn, E., Schirmbeck, R., Reimann, J., and Autenrieth, I. B. (1999). DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur. J. Immunol. 29, 986-996.
264. O'Brien, L., Roberts, B., and Andrew, P. W. (1996). In vitro interaction of Mycobacterium tuberculosis and macrophages; Activation of anti-mycobacterial activity of macrophages and mechanisms of anti-mycobacterial immunity. Curr. Top. Microbiol. Immunol. 215, 97-101.
265. O'Callaghan, D., Maskell, D., Liew, F. Y., Easmon, C. S., and Dougan, G. (1988). Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56, 419-423.
266. O'Callaghan, D., Maskell, D., Tite, J., and Dougan, G. (1990). Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains. Immunology 69, 184-189.
267. Paglia, P., Arioli, I., Frahm, N., Chakraborty, T., Colombo, M. P., and Guzman, C. A. (1997). The defined attenuated Listeria, monocytogenes delta mp12 mutat is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma. Eur. J. Immunol. 27, 1570-1575.
268. Paglia, P., Chiodoni, C., Rodolfo, M., and Colombo, M. P. (1996). Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183, 317-322.
269. Paglia, P., Medina, E., Arioli, I., Guzman, C. A., and Colombo, M. P. (1998). Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92, 3172-3176.
270. Pamer, E. G. (1994). Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J. Immunol. 152, 686-694.
271. Pamer, E. G. (1998). Cell-mediated immunity: The role of bacterial protein secretion. Curr. Biol. 8, 457-460.
272. Pamer, E. G., Harty, J. T., and Bevan, M. J. (1991). Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353, 852-855.
273. Pan, Z. K., Ikonomidis, G., Lazenby, A., Pardoll, D., and Paterson, Y. (1995a). A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumors. Nat. Med. 1, 471-477.
274. Pan, Z. K., Ikonomidis, G., Pardoll, D., and Paterson, Y. (1995b). Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine. Cancer Res. 55, 4776-4779.
275. Pang, T., Levine, M. M., Ivanoff, B., Wain, J., and Finlay, B. B. (1998). Typhoid fever-important issues still remain. Trends Microbiol. 6, 131-133.
276. Panum, P. L. (1847). Beobachtungen über das Masern Contagium. Virchows Archiv, 1, 492-502.
277. Parrish, N. M., Dick, J. D., and Bishai, W. R. (1998). Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6, 107-112.
278. Paterson, Y. (1999). The relationship between intracellular bacterial life-styles and immune responsiveness to bacterial delivered antigens. In "Intracellular Bacterial Vaccine Vectors" (Y. Paterson, ed.), pp. 1-23. John Wiley & Sons, New York.
279. Paul, J. R., Riordan, J. T., and Melnick, J. L. (1951). Antibodies to three different antigenic types of poliomyelitis virus in sera from North Alaskan Eskimos. Am. J. Hygiene 54, 275-285.
280. Pelicic, V., Jackson, M., Reyrat, J. M., Jacobs, W. R. J., Gicquel, B., and Guilhot, C. (1997). Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 94, 10955-10960.
281. Peterson, E. M., Cheng, X., Motin, V. L., and delaMaza, L. M. (1997). Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection. Infect. Immun. 65, 2693-2699.
282. Pfeffer, K., Schoel, B., Gulle, H., Kaufmann, S. H. E., and Wagner, H. (1990). Primary responses of human T cells to mycobacteria: A frequent set of γ/δ T cells are stimulated by protease-resistant ligands. Eur. J. Immunol. 20, 1175-1179.
283. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., and Hartding, C. V. (1993). Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361, 359-362.
284. Piedrafita, D. (1999). Protective immune responses induced by vaccination with an expression genomic library of leishmania major. J. Immunol. 163, 1467-1472.
285. + T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity. Immunology 81, 183-191.
286. + cytotoxic T lymphocytes following primary and secondary Salmonella infection. Immunology 81, 177-182.
287. Porcelli, S., Morita, C. T., and Brenner, M. B. (1992). CD1b restricts the response of human Cd4-8-T lymphocytes to a microbial antigen. Nature 360, 593-597.
288. Porcelli, S. A. (1995). The CD1 family: A third lineage of antigen-presenting molecules. Adv. Immunol. 59, 1-98.
289. Porcelli, S. A., and Modlin, R. L. (1999). The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17, 297-329.
290. Porcelli, S. A., Segelke, B. W., Sugita, M., Wilson, I. A., and Brenner, M. B. (1998). The CD1 family of lipid antigen-presenting molecules. Immunol. Today 19, 362-368.
291. Porgador, A., Irvine, K. R., Iwasaki, A., Barber, B. H., Restifo, N. P., and Germain, R. N. (1998). Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. 188, 1075-1082.
292. Power, C. A., Wei, G., and Bretscher, P. A. (1998). Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect. Immun. 66, 5743-5750.
293. Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., and Maliszewski, C. R. (1999). Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96, 1036-1041.
294. Raposo, G., Nijman, H. W., Stoorvogel, W., Leijendecker, R., Harding, C. V., Melief, C. J., and Geuze, H. J. (1996). B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172.
295. Redman, T. K., Harmon, C. C., Michalek, S. M., Hoiseth, S. K., and Stocker, B. A. (1996). Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A (SpaA) of Streptococcus sobrinus: Effects of the Salmonella virulence plasmid on the induction of protective and sustained humoral responses in rats. Aromatic-dependent Salmonella typhimurium are non-virulent and effect as live vaccines. Vaccine 14, 868-878.
296. Reimann, J., and kaufmann, S. H. (1997). Alternative antigen processing pathways in anti-infective immunity. Cur. Opin. Immunol. 9, 462-469.
297. Rhoades, E. R., and Orme, I. M. (1997). Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates. Infect. Immun. 65, 1189-1195.
298. Robbe-Saule, V., and Norel, F. (1999). The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine vaccine Ty21a. FEMS Microbiol. Lett. 170, 141-143.
299. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., and O. Garra, A. (1997). IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7, 571-581.
300. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., and Amigorena, S. (1999). Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nature Cell Biol. 1, 362-368.
301. Rolph, M. S., and Ramshaw, I. A. (1997). Recombinant viruses as vaccines and immunological tools. Curr. Opin. Immunol. 9, 517-524.
302. Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., and Raz, E. (1997). Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3, 849-854.
303. Rosat, J. P., Grant, E. P., Beekman, E. M., Dascher, C. C., Sieling, P. A., Frederique, D., Modlin, R. L., Porcelli, S. A., Furlong, S. T., and Brenner, M. B. (1999). CD1-restricted microbial lipid antigen-specific recognition found in the CD8(+) alpha beta T cell pool. J. Immunol. 162, 366-371.
304. Russell, D. G., Sturgill-Koszycki, S., Vanheyningen, T., Coffins, H., and Schaible, U. E. (1997). Why intraceullar parasitism need not be a degrading experience for Mycobacterium. Philosoph. Trans. Roy. Soc. London - Series B: Biol. Sci. 352, 1303-1310.
305. Russmann, H., Shams, H., Poblete, F., Fu, Y., Galan, J. E., and Donis, R. O. (1998). Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281, 565-568.
306. Ryan, E. T., Butterton, J. R., Smith, R. N., Carroll, P. A., Crean, T. I., and Calderwood, S. B. (1997). Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect. Immun. 65, 2941-2949.
307. Saito, H., Kanamori, Y., Takemori, T., Nariuchi, H., Kubota, E., Takahashi-Iwanaga, H., Iwanaga, T., and Ishikawa, H. (1998). Generation of intestinal T cells from progenitors residing in gut cryptopatches. Science 280, 275-278.
308. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400.
309. Sansonetti, P. J., and Phalipon, A. (1999). M cells as ports of entry for enteroinvasive pathogens: Mechanisms of interaction, consequences for the disease process. Sem. Immunol. 11, 193-203.
310. Sawyer, W. A. (1931). Persistance of yellow fever immunity. J. Prev. Med. 5, 413-428.
311. Schaible, U. E., Collins, H. L., and Kaufmann, S. H. (1999). Confrontation between intracellular bacteria and the immune system. Adv. Immunol. 71, 267-377.
312. Schaible, U. E., Sturgill-Koszycki, S., Schlesinger, P. H., and Russell, D. G. (1998). Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160, 1290-1296.
313. Schena, M., Heller, R. A., Theriault, T. P., Konrad, K., Lachenmeier, E., and Davis, R. W. (1998). Microarrays: Biotechnology's discovery platform for functional genomics. Trends Biotechnol. 16, 301-306.
314. Schirmbeck, R., Bohm, W., and Reimann, J. (1997). Stress protein (hsp73)-mediated TAP-independent processing of endogenous, truncated SV40 large T antigen for D-b-restricted peptide presentation. Eur. J. Immun. 27, 2016-2023.
315. Schirmbeck, R., and Reimann, J. (1996). "Empty" Ld molecules
316. Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L., and Hill, A. V. (1998). Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4, 397-402.
317. Schoel, B., and Kaufmann, S. H. E. (1996). The unique role of heat shock proteins in infections. In "Stress Proteins in Medicine," (Van Eden and Young, eds.), pp. 27-51. Marcel Dekker Inc., New York, Basel, Hong Kong.
318. Schoel, B., Sprenger, S., and Kaufmann, S. H. (1994). Phosphate is essential for stimulation of V gamma 9V delta 2 T lymphocytes by mycobacterial low molecular weight ligand. Eur. J. Immunol. 24, 1886-1892.
319. Schofield, L., McConville, M. J., Hansen, D., Campbell, A. S., Fraser-Reid, B., Grusby, M. J., and Tachado, S. D. (1999). CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283, 225-229.
320. Sedegah, M., Hedstrom, R., Hobart, P., and Hoffman, S. L. (1994). Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91, 9866-9870.
321. Sedegah, M., Jones, T. R., Kaur, M., Hedstrom, R., Hobart, P., Tine, J. A., and Hoffman, S. L. (1998). Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 95, 7648-7653.
322. Shen, H., Miller, J. F., Fan, X., Kolwyck, D., Ahmed, R., and Harty, J. T. (1998). Compartmentalization of bacterial antigens: Differential effects on priming of CD8 T cells and protective immunity. Cell 92, 535-545.
323. Shen, H., Slifka, M. K., Matloubian, M., Jensen, E. R., Ahmed, R., and Miller, J. F. (1995). Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. USA 92, 3987-3991.
324. Shimada, S., Yano, O., and Tokunaga, T. (1986). In vivo augmentation of natural killer cell activity, with a deoxyribonucleic acid fraction of BCG. Jap. Natl. Cancer Inst. 74, 808-816.
325. Shimizu, Y., Guidotti, L. G., Fowler, P., and Chisari, F. V. (1998). Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 161, 4520-4529.
326. Shiver, J. W., Ulmer, J. B., Donnelly, J. J., and Liu, M. A. (1996). Naked DNA vaccination. In "Concepts in Vaccine Development" (S. H. E. Kaumann, ed.), pp. 423-436. Walter de Gruyter, Berlin, New York.
327. Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J., and Modlin, R. L. (1995). CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230.
328. Sigwart, D. F., Stocker, B. A., and Clements, J. D. (1989). Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. Infect. Immun. 57, 1858-1861.
329. Silva, B. A., Gonzalez, C., Mora, G. C., and Cabello F. (1987). Genetic characteristics of the Salmonella typhi strain Ty21a vaccine [published erratum appears in J. Infect. Dis. 1987 Aug; 156(2): 421]. J. Infect. Dis. 155, 1077-1078.
330. Silva, C. L., Silva, M. F., Pietro, R. C., and Lowrie, D. B. (1994). Protection against tuberculosis by passive transfer with T-cell clones recognizing mycobacterial heat-shock protein 65. Immunology 83, 341-346.
331. Silva, R. A., Pais, T. F., and Appelberg, R. (1998). Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections. J. Immunol. 161, 5578-5585.
332. Sin, J. I., Kim, J. J., Arnold, R. L., Shroff, K. E., McCallus, D., Pachuk, C., McElhiney, S. P., Wolf, M. W., Pompa-de Bruin, S.J., Higgins, T. J., Ciccarelli, R. B., and Weiner, D. B. (1999). IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. 162, 2912-2921.
333. Sinai, A. P., and Joiner, K. A. (1997). Safe haven: The cell biology of nonfusogenic pathogen vacuoles. Annu. Rev. Microbiol. 51, 415-462.
334. Sirard, J. C., Fayolle, C., Dechastellier, C., Mock, M., Leclerc, C., and Berche, P. (1997). Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes. J. Immunol. 159, 4435-4443.
335. Sizemore, D. R., Branstrom, A. A., and Sadoff, J. C. (1995). Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 270, 299-302.
336. Skeen, M. J., and Ziegler, H. K. (1993). Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection. J. Exp. Med. 178, 971-984.
337. Slifka, M. K., and Ahmed, R. (1998). Long lived plasma cells: A mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 10, 252-258.
338. Slifka, M. K., Shen, H., Matloubian, M., Jensen, E. R., Miller, J. F., and Ahmed, R. (1996). Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. J. Virol. 70, 2902-2910.
339. Sonnenberg, M. G., and Belisle, J. T. (1997). Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect. Immun. 65, 4515-4524.
340. Starnbach, M. N., Bevan, M. J., and Lampe, M. F. (1994). Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J. Immunol. 153, 5183-5189.
341. Steffen, R., Schar, G., and Mosimann, J. (1981). Salmonella and Shigella infections in Switzerland, with special reference to typhoid vaccination for travellers. Scandinavian J. Infect. Dis. 13, 121-127.
342. Steinhoff, U., Brinkmann, V., Klemm, U., Aichele, P., Seiler, P., Brandt, U., Bland, P. W., Prinz, L, Zügel, U., Kaufmann, S. H. E. (1999). Autoimmune intestinal pathology induced by hsp60 specific CD8 T cells. Immunity 11, 349-358.
343. Stenger, S., Hanson, D. A., Teitelbaum, R., Dewan, P., Niazi, K. R., Froelich, C. J., Ganz, T., Thoma-Uszynski, S., Melian, A., Bogdan, C., Porcelli, S. A., Bloom, B. R., Krensky, A. M., and Modlin, R. L. (1998). An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121-125.
344. Stenger, S., Mazzaccaro, R. J., Uyemura, K., Cho, S., Barnes, P. F., Rosat, J. P., Sette, A., Brenner, M. B., Porcelli, S. A., Bloom, B. R., and Modlin, R. L. (1997). Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684-1687.
345. Stenger, S.,and Modlin, R. L. (1999). T cell mediated immunity to Mycobacterium tuberculosis Curr. Opin. Microbiol. 2, 89-93.
346. Stephens, K. S. (1999). "Chlamydia: Intracellular Biology, Pathogenesis, and Immunity." ASM Press.
347. Stephens, R. S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., Olinger, L., Tatusov, R. L., Zhao, Q., Koonin, E. V., and Davis, R. W. (1998). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282, 754-759.
348. Stocker, B. A. (1993). Attenuation in Salmonella by Auxotrophy. In "Biology of Salmonella" (F. Caballo, ed.), pp. 309-322. Plenum Press, New York.
349. Stover, C. K., Bansal, G. P., Hanson, M. S., Burlein, J. E., Palaszynski, S. R., Young, J. F., Koenig, S., Young, D. B., Sadziene, A., and Barbour, A. G. (1993). Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate Lyme disease vaccine. J. Exp. Med. 178, 197-209.
350. Stover, C. K., de, I. C., V, Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, LT, Bansal, G. P., Young, J. F., Lee, M. H., and Hatfull, G. F. (1991). New use of BCG for recombinant vaccines. Nature 351, 456-460.
351. Su, H., Feilzer, K., Caldwell, H. D., and Morrison, R. P. (1997). Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65, 1993-1999.
352. Su, H., Messer, R., Whitmire, W., Fischer, E., Portis, J. C., and Caldwell, H. D. (1998). Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J. Exp. Med. 188, 809-818.
353. Sugita, M., and Brenner, M. B. (1995). Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 270, 1443-1448.
354. Svensson, M., Pfeifer, J., Stockinger, B., and Wick, M. J., (1997). Bacterial antigen delivery systems: Phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells. Behring Institute Mitteilungen 98, 197-211.
355. Svensson, M., Stockinger, B., and Wick, M. J. (1997). Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J. Immunol. 158, 4229-4236.
356. Svensson, M., and Wick, M. J. (1999). Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells. Eur. J. Immunol. 29, 180-188.
357. Swain, S. L. (1994). Generation and in-vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1, 543-552.
358. Szalay, G., Ladel, C. H., Blum, C., Brossay, L., Kronenberg, M., and Kaufmann, S. H. E. (1999a). Cutting edge: Anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice. J. Immunol. 162, 6955-6958.
359. Szalay, G., Zügel, U., Ladel, C. H., and Kaufmann, S. H. E. (1999b). Participation of group II CD1 molecules in the control of murine tuberculosis. Microbes Infect. 1, 1153-1158.
360. Sztein, M. B., Tanner, M. K., Polotsky, Y., Orenstein, J. M., and Levine, M. M. (1995). Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J. Immunol. 155, 3987-3993.
361. Sztein, M. B., Wasserman, S. S., Tacket, C. O., Edelman, R., Hone, D., Lindberg, A. A., and Levine, M. M. (1994). Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170, 1508-1517.
362. Tacket, C. O., Hone, D. M., Curtiss, R., Kelly, S. M., Losonsky, G., Guers, L., Harris, A. M., Edelman, R., and Levine, M. M. (1992a). Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect. Immun. 60, 536-541.
363. Tacket, C. O., Hone, D. M., Losonsky, G. A., Guers, L., Edelman, R., and Levine, M. M. (1992b). Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 10, 443-446.
364. Tacket, C. O., Kelly, S. M., Schodel, F., Losonsky, G., Nataro, J. P., Edelman, R., Levine, M. M., and Curtiss, R. (1997a). Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system [published erratum appears in Infect. Immun. 1997 Sep; 65 (9): 3981]. Infect. Immun. 65, 3381-3385.
365. Tacket, C. O., Losonsky, G., Taylor, D. N., Baron, L. S., Kopecko, D., Cryz, S., and Levine, M. M. (1991). Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies. J, Infect. Dis. 163, 901-904.
366. Tacket, C. O., Sztein, M. B., Losonsky, G. A., Wasserman, S. S., Nataro, J. P., Edelman, R., Pickard, D., Dougan, G., Chatfield, S. N., and Levine, M. M. (1997b) Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65, 452-456.
367. Tamura, Y., Peng, P., Liu, K., Daou, M., and Srivastava, P. K. (1997). Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278, 117-120.
368. Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O'Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., and Callan, M. F. C. (1999). A re-evaluation of the frequency of CD8(+) T cells specific for EBV in healthy virus carriers. J. Immunol. 162, 1827-1835.
369. Tan, M. C., Mommaas, A. C., Drijfhout, J. W., Jordens, R., Onderwater, J. J., Verwoerd, D., Mulder, A. A., van der Heiden, A. N., Scheidegger, D., Oomen, L. C., Ottenhoff, T. H., Tulp, A., Neefjes, J. J., and Koning, F. (1997). Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27, 2426-2435.
370. Tanaka, Y., Morita, C. T., Nieves, E., Brenner, M. B., and Bloom, B. R. (1995). Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 375,155-158.
371. Tanaka, Y., Sano, S., Nieves, E., De Libero, G., Rosa, D., Modlin, R. L., Brenner, M. B., Bloom, B. R., and Morita, C. T. (1994). Nonpeptide ligands for human γδ T cells. Proc. Natl. Acad. Sci. USA 91, 8175-8179.
372. Tanchot, C., Lemonnier, F. A., Perarnau, B., Freitas, A. A., and Rocha, B. (1997). Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276, 2057-2062.
373. Tanghe, A., Lefevre, P., Denis, O., D'Souza, S., Braibant, M., Lozes, E., Singh, Montgomery, D., Content, J., and Huygen, K. (1999). Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J. Immunol. 162, 1113-1119.
374. Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D., and Lowrie, D. B. (1996). Vaccination against tuberculosis by DNA injection. Nat. Med. 2, 888-892.
375. Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A., and Bloom, B. R. (1998). A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl. Acad. Sci. USA 95, 15688-15693.
376. Teitelbaum, R., Schubert, W., Gunther, L., Kress, Y., Macaluso, F., Pollard, J. W., McMurray, D. N., and Bloom, B. R. (1999). The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity 10, 641-650.
377. Teitell, M., Holcombe, H. R., Brossay, L., Hagenbaugh, A., Jackson, M. J., Pond, L., Balk, S. P., Terhorst, C., Peterson, P. A., and Kronenberg, M. (1997). Nonclassical behavior of the mouse CD1 class I-like molecule. J, Immunol. 158, 2143-2149.
378. Tew, J. G., and Mandel, T. E. (1979). Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice. Immunology 37, 69-76.
379. Tokunaga, T., Yamamoto, H., Shimada, S., Abe, H., Fukuda, T., Fujiisawa, Y., Furutani, Y., Yano, O., Kataoka, T., and Sudo, T. (1984). Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Isolation, physicochemical characterization, and tumor activity. Jap. Natl. Cancer Inst. 72, 955-962.
380. Turner, J., and Dockrell, H. M. (1996). Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 87, 339-342.
381. Turner, S. J., Carbone, F. R., and Strugnell, R. A. (1993). Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect. Immun. 61, 5374-5380.
382. Tzschaschel, B. D., Klee, S. R., Delorenzo, L. V., Timmis, K. N., and Guzman, C. A. (1996). Towards a vaccine candidate against Shigella dysenteriae 1: Expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain. Microb. Pathogen. 21 277-288.
383. Uchijima, M., Yoshida, A., Nagata, T., and Koide, Y. (1998). Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J, Immunol. 161, 5594-5599.
384. Udono, H., Levey, D. L., and Srivastava, P. K. (1994). Cellular requirements for tumorspeicific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA 91, 3077-3081.
385. Udono, H., and Srivastava, P. K. (1993). Heat shock protein 70-associated peptides elicit specific cancer immunity. J, Exp. Med. 178, 1391-1396.
386. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., and Friedman, A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
387. Valentine, P. J., Meyer, K., Rivera, M. M., Lipps, C., Pauza, D., Maziarz, R. T., So, and Heffron, F. (1996). Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant. Vaccine 14, 138-146.
388. Vancott, J. L., Chatfield, S. N., Robets, M., Hone, D. M., Hohmann, E. L., Pascual, D. W., Yamamoto, M., Kiyono, H., and McGhee, J. R. (1998). Regulation of host immune responses by modification of Salmonella virulence genes. Nat. Med. 4, 1247-1252.
389. Van Eden, W., Holoshitz, J, and Cohen, I. (1987). Antigenic mimicry between mycobacteria and cartilage proteoglycans: The model of adjuvant arthritis. Concepts Immunopathol. 4, 144-170.
390. Van Eden, W., Thole, J. E., van der Zee, R., Noordji, A., van Embden, J. D., Hensen, E. J., and Cohen, I. R. (1988). Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331, 171-173.
391. Venkataprasad, N. (1999). Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers. Vaccine 17, 1814-1819.
392. Verbon, A., Hartskeerl, R. A., Schuitema, A., Kolk, A. H., Young, D. B., and Lathigra, R. (1992). The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J. Bacteriol. 174, 1352-1359.
393. Verma, N. K., Ziegler, H. K., Stocker, B. A. D., Schoolnik, G. K. (1995). Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella. Vaccine 13, 235-244.
394. Vogel, F. R., and Powell, M. F. (1995). A compendium of vaccine adjuvants and excipients. In "Vaccine Design: The Subunit and Adjuvant Approach" (M. F. Powell and M. J. Newman, eds.), pp. 141-228. Plenum Press, New York.
395. Wagner, H. (1999). Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol. 73, 329-368.
396. Wagner, R. D., Steinberg, H., Brown, J. F., and Czuprynski, C. J. (1994). Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microb. Pathogen. 17, 175-186.
397. Wahdan, M. H., Serie, C., Cerisier, Y., Sallam, S., and Germanier, R. (1982). A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: Three-year results. J. Infect. Dis. 145, 292-295.
398. Wang, R., Doolan, D. L., Le, T. P., Hedstrom, R. C., Coonan, K. M., Charoenvit, Y., Jones T. R., Hobart, P., Margalith, M., Ng, J., Weiss, W. R., Sedegah, M., DE, Taisne, C., Norman, J. A., and Hoffman, S. L. (1998). Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-480.
399. Watts, C. (1997). Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15, 821-850.
400. Weiskirch, L., and Paterson, Y. (1999). The use of Listeria, monocytogenes recombinants as vaccine vectors in infectious and neoplastic disease. In "Intracellular Bacterial Vaccine Vectors" (Y. Paterson, ed.), pp. 223-260, John Wiley & Sons, New York.
401. Weiskirch, L. M., and Paterson, Y. (1997). Listeria monocytogenes: A potent vaccine vector for neoplastic and infectious disease. Immunol. Rev. 158, 159-169.
402. White, D. W., Wilson, R. L., and Harty, J. T. (1996). CD8+ T cells in intracellular bacterial infections of mice. Res. Immunol. 147, 519-524.
403. Wick, M. J., and Pfeifer, J. D. (1996). Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: Protein context influences the degree of TAP-independent presentation. Eur. J. Immunol. 26, 2790-2799.
404. Wiker, H. G., and Harboe, M. (1992). The antigen 85 complex: A major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56, 648-661.
405. Winkle, S. (1997). "Geisseln der Menschheit: Kulturgeschichte der Seuchen."
406. Winter, N., Lagranderie, M., Gangloff, S., Leclerc, C., Gheorghiu, M., and Gicquel, B. M. (1995). Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against net synthetic peptides in mice. Vaccine 13, 471-478.
407. Wong, D. K., Lee, B. Y., Horwitz, M. A., and Gibson, B. W. (1999). Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined two-dimensioanl gel electrophoresis and mass spectrometry. Infect. Immun. 67, 327-336.
408. World Health Organization. (1999). "The World Health Report 1999: Making a Difference."
409. Wuenscher, M. D., Kohler, S., Bubert, A., Gerike, U., and Goebel, W. (1993). The iap gene of Listeria monocytogenes is essential for cell viability, and its gene product, p60, has bacteriolytic activity. J. Bacteriol. 175, 3491-3501.
410. Xiang, Z., and Ertl, H. C. (1995). Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129-135.
411. Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O., and Tokunaga, T. (1992). Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J. Immunol. 148, 4072-4076.
412. Yasutomi, Y., Koenig, S., Haun, S. S., Stover, C. K., Jackson, R. K., Conard, P., Conley, A. J., Emini, E. A., Fuerst, T. R., and Letvin, N. L. (1993). Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 150, 3101-3107.
413. Yasutomi, Y., Koenig, S., Woods, R. M., Madsen, J., Wassef, N. M., Alving, C. R., Klein, H. J., Nolan, T. E., Boots, L. J., and Kessler, J. A. (1995). A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J. Virol. 69, 2279-2284.
414. York, I. A., and Rock, K. L. (1996). Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14, 369-396.
415. Yuan, Y., Crane, D. D., Simpson, R. M., Zhu, Y. Q., Hickey, M. J., Sherman, D. R., and Barry, C. E. (1998). The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc. Natl. Acad. Sci. USA 95, 9578-9583.
416. Zarozinski, C. C., Fynan, E. F., Selin, L. K., Robinson, H. L., and Welsh, R. M. (1995). Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154, 4010-4017.
417. Zhang, D., Yang, X., Berry, J., Shen, C., McClarty, G., and Brunham, R. C. (1997). DNA vaccination with the major outer-membrane protein gene induces acquired immuniy to Chlamydia trachomatis (mouse pneumonitis) infection. J. Infect. Dis. 176, 1035-1040.
418. Zhang, J. P., and Stephens, R. S. (1992). Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 69, 861-869.
419. Zitvogel, L., Regnault, A., Lozier A, Wolfers, J., Flament, C. T., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., and Amigorena, S. (1998). Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell drived exosomes. Nat. Med. 4, 594-600.
420. Zinsser, H., and Bayne-Jones, S. (1934). "A Textbook of Bacteriology." D. Appleton Century Co., New York, London.
421. Zügel, U., and Kaufmann, S. H. E. (1999). Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin. Microbiol. Rev. 12(1), 19-39.
422. Zügel, U., and Kaufmann, S. H. E. (1999). Gp96-peptide vaccination of mice against intracellular bacteria. Submitted.